Biotech news for Thursday, June 18, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Wall Street futures edged lower early Wednesday as investors weighed escalating Middle East tensions following U.S. retaliatory strikes on Iran against upcoming tech sector developments.Wall Street futures edged lower early Wednesday as investors weighed escal…
Moderna ( MRNA ) shares reached the highest level since March after the FDA issued comments that Jefferies said gave a “balanced” view on the company’s flu vaccine candidate, mRNA-1010, ahead of an advisory committee meeting later this week. The regulator agre…
alexsl Shares of Aktis Oncology ( AKTS ) traded higher on Tuesday after Raymond James initiated its coverage with a Strong Buy rating and a $40 target based on the company’s radioligand therapy (RLT) platform and its ongoing partnership with Eli Lilly (
Toa55/iStock via Getty Images The US FDA has approved AbbVie's ( ABBV ) Skinvive by Juvederm, a hyaluronic acid injectable to reduce the appearance of neck wrinkles. Skinvive "reduces neck lines formed by tech-neck by helping the skin retain its natural moistu…
Grandbrothers/iStock Editorial via Getty Images Outlook Therapeutics ( OTLK ) traded higher in the premarket on Tuesday after the U.S. Food and Drug Administration agreed to reconsider its marketing application for ONS-5010, a treatment targeting the eye disor…
Canton Strategic ( CNTN ) announced on Tuesday that its Board of Directors has authorized a share repurchase program granting the company authority to repurchase up to $50M in common stock. Shares of CNTN gained nearly 2% during pre-market trading hours on Tue…